Multiphasic Effects of Cholesterol on Influenza Fusion Kinetics Reflect Multiple Mechanistic Roles  by Domanska, Marta K. et al.
Biophysical Journal Volume 105 September 2013 1383–1387 1383Multiphasic Effects of Cholesterol on Influenza Fusion Kinetics Reflect
Multiple Mechanistic RolesMarta K. Domanska,†‡ Dominik Wrona,†‡ and Peter M. Kasson†‡*
†Department of Molecular Physiology and Biological Physics and ‡Department of Biomedical Engineering, University of Virginia,
Charlottesville, VirginiaABSTRACT The envelope lipid composition of influenza virus differs from that of the cellular plasma membrane from which it
buds. Viruses also appear to fuse preferentially to specific membrane compartments, suggesting that the lipid environment may
influence permissiveness for fusion. Here, we investigated the influence of the membrane environment on fusion, focusing on
cholesterol composition. Strikingly, manipulating cholesterol levels in the viral membrane had different effects on fusion kinetics
compared with analogous changes to the target membrane. Increasing cholesterol content in target vesicles increased lipid- and
contents-mixing rates. Moderate cholesterol depletion from the viral membrane sped fusion rates, whereas severe depletion
slowed the process. The pleiotropic effects of cholesterol include alterations in both membrane-bending moduli and lateral
organization. Because influenza virions have demonstrated cholesterol-dependent lateral organization, to separate these
effects, we deliberately selected a target vesicle composition that does not support lateral heterogeneity. We therefore postulate
that the monotonic response of fusion kinetics to target membrane cholesterol reflects bending and curvature effects, whereas
the multiphasic response to viral cholesterol levels reflects the combined effects of lateral organization and material properties.INTRODUCTIONMembrane fusion is a crucial step in cell entry by enveloped
viruses. In influenza virus, endosomal acidification causes
rearrangement of the coat protein hemagglutinin, leading
to exposure of fusion peptides that insert into the endosomal
membranes and drive fusion (1,2). This is a dynamic
process, and fusion intermediates are often studied by
monitoring lipid and contents exchange between fusion
partners (3). Mutagenesis studies have identified changes
to the membrane-inserted fusion peptides that block fusion
altogether or permit lipid exchange but not contents ex-
change (4–6). This can be interpreted to indicate at least
two free-energy barriers to influenza fusion: one preceding
lipid exchange and one after lipid but before contents
exchange.
In addition to viral proteins, the lipid environment of both
the viral envelope and the host cell can greatly influence the
fusion process. Circumstantial evidence for this has long
existed, as viral infection alters lipid synthesis pathways
(7) and mature virus differs in lipid composition from either
the membrane whence it came or uninfected cells (8).
Cholesterol in particular is enriched in influenza virus (9).
Cholesterol is of special interest because it can stabilize
curved negatively membrane structures (10,11), can control
lateral membrane organization (12,13), and is readily
manipulable (unlike many lipid species, cholesterol can be
easily added to or extracted from intact membranes).
Cholesterol’s effects on membrane fusion have been exten-
sively studied, and cholesterol has been shown to beSubmitted February 11, 2013, and accepted for publication August 6, 2013.
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0006-3495/13/09/1383/5 $2.00necessary for efficient neuronal exocytosis and enveloped
viral entry (14–18).
To further probe the effects of cholesterol on influenza
viral fusion, we studied how changes to viral or target
membrane cholesterol affect fusion kinetics. Here, we report
the use of fluorescence dequenching to measure fusion
kinetics between live influenza virus and manipulable model
membranes as a function of cholesterol content. Viral
envelopes contain a complex lipid mixture; therefore, to
separate the potential effects of cholesterol on lateral
organization and curvature, we either extracted cholesterol
from the native viral envelope or constructed simple target
liposomes with varying amounts of cholesterol. We chose
to use a target liposomal composition that does not support
liquid-liquid phase coexistence.MATERIALS AND METHODS
We used liposomes composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC)/palmitoyloleoylphosphatidylethanolamine (POPE)/
cholesterol (Chol)/NBD-dioleyl phosphatidylethanolamine (NBD-DOPE)/
Rhodamine-DOPE extruded at 100 nm with aminonaphthalene-trisulfonic
acid (ANTS)/p-xylene-bis-pyridinium bromide (DPX) complex encapsu-
lated to monitor lipid and contents mixing simultaneously. Experiments
were performed with excess DPX in the fusion buffer to suppress fluores-
cence signal from leakage and primarily measure contents mixing. We also
performed controls without DPX in the buffer to assess leakiness during
fusion. The resulting contents-release data (mixing þ leakage) produced
curve shapes that were indistinguishable from those obtained with mixing
alone, indicating an absence of detectable leakage preceding fusion
(Fig. 1). Additionally, solution measurements of ANTS fluorescence
showed that the ANTS/DPX ratio present after total contents leakage
was sufficient to quench >90% of ANTS fluorescence (Fig. S1 in the
Supporting Material). Additional controls measuring dequenching of
encapsulated ANTS alone with and without DPX in the fusion buffer
suggested that minor leakage did occur, but that >90% of the signal inhttp://dx.doi.org/10.1016/j.bpj.2013.08.003
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FIGURE 1 (A) Schema of the fusion assay. Fusion of influenza virus with
labeled liposomes is monitored via fluorescence dequenching of lipidic and
solution-phase dyes. Lipid mixing causes dilution of the NBD-DOPE and
Rh-DOPE FRET pair, and thus an increase in NBD fluorescence. Contents
mixing causes dilution of the ANTS/DPX complex and an increase in
ANTS fluorescence. Additional DPX is present in the external buffer to
quench free ANTS and differentiate mixing from leakage. (B) Representa-
tive traces with and without excess DPX in the external buffer.
A
B
1384 Domanska et al.fusion experiments with encapsulated ANTS/DPX was due to mixing (see
Supporting Material).Influenza virus
Egg-grown influenza virus X:31 (H3N2 A/Aichi/68) was purchased from
Charles River Laboratories (Wilmington, MA). Cholesterol was extracted
via incubation with 0, 10, 20, or 50 mM methyl-b-cyclodextrin (MbCD)
at 37C for 30 min. Virus was then reisolated from cyclodextrin-cholesterol
complexes via centrifugation at 4C, 14,000 rpm for 40 min, and then resus-
pended in buffer (10 mM phosphate/90 mM citrate/150 mM NaCl, pH 7.4).FIGURE 2 Lipid- and contents-mixing rates at different cholesterol com-
positions. (A and B) Rates of lipid mixing (A) and contents mixing (B) were
determined via single-exponential fits to fluorescence dequenching traces.
Mixing rates show a consistent increase with increasing mole fraction
cholesterol in target vesicles. A biphasic response is observed with progres-
sive cholesterol extraction from the virus. Each bar represents the median of
five to 13 measurements. These trends can be visualized more clearly in
Figure 3.Target liposomes
Large unilamellar vesicles (LUVs) composed of 30 mol % POPE, 1.5 mol
% NBD-DOPE, 1.5 mol % Rh-DOPE, 10–40 mol % Chol (as specified),
and the remaining 30–67 mol % POPC were extruded at 100 nm with
ANTS/DPX contents dye encapsulated (internal concentration: 12.5 mM
ANTS/45 mM DPX) and isolated by size-exclusion chromatography.
Further details are given in the Supporting Material.Biophysical Journal 105(6) 1383–1387Fusion assay
Virus-liposome fusion was monitored via lipid and contents mixing, and
assayed by fluorescence dequenching of the lipidic fluorescence resonance
energy transfer (FRET) pair NBD/Rh and dissociation and dequenching of
the soluble ANTS/DPX complex. Virus (standardized at 60 mg of viral pro-
tein) was mixed with target liposomes (0.2 mM total lipid), adjusted to a
final buffer concentration of 30 mM DPX, and incubated for 30 min at
4C. The reaction mixture was then warmed and equilibrated at 37C
over 15 min. Fusion was triggered by acidification to pH 5.0 using 2 mM
citric acid, and fluorescence was monitored in a fluorescence plate reader.
Excitation and emission wavelengths were set at 460 nm/538 nm (with a
530 nm cutoff filter) and 360 nm/530 nm (with a 515 nm cutoff filter) for
NBD/Rh and ANTS/DPX, respectively. Lipid mixing values were normal-
ized as follows: Inorm ¼ (Iobs – I0) / (Imax – I0), where I0 is the fluorescence
reading before acidification and Imax is the fluorescence reading after addi-
tion of Triton X-100 to a final concentration of 1%. Contents-mixing values
were reported only as the relative increase in fluorescence over baseline:
Irel ¼ Iobs / I0  1. Fusion rates were determined via fitting to a single-
exponential equation with a phase-shift parameter to allow for an experi-
mental time lag between acidification and t ¼ 0 time of fluorescence
measurement. This yielded the following fit equation: Inorm(t) ¼ a * (1 
exp(b * (t þ t0))). Lipid dye transfer was observed only under conditions
of fusion (Fig. S2), and contents dequenching was almost completely
Cholesterol Effects on Influenza Fusion 1385attributable to mixing, as measured by fluorescence of isolated fusion
products (Table S1). Further details and dequenching controls are reported
in the Supporting Material.RESULTS AND DISCUSSION
To test how fusion kinetics change with target membrane
composition, we varied the mole fraction cholesterol in
target liposomes from 10 to 40 mol %. Fig. 2 A summarizes
the lipid-mixing rates for our virus-liposome fusion experi-
ments; normalized fusion rates are plotted as a function of
liposomal cholesterol content in Fig. 3 A. Under all viral
conditions tested, increasing liposomal cholesterol
increased the fusion rates. We observed a nearly identical
effect on contents mixing (Figs. 2 B and 3 B). Lipid-mixing
rates of virus that was not treated with methyl-b-cyclodex-
trin increased 2.4-fold from 10 to 40 mol % liposomal
cholesterol (0.014 s1 to 0.033 s1). Similarly, the con-
tents-mixing rate increased 2.3-fold (0.013 s1 to 0.031
s1). Similar increases were observed at all viral cholesterol
levels, indicating that increasing the cholesterol content of
target membranes robustly speeds fusion independently of
the viral membrane composition. Furthermore, we observed
similar trends whether we held the mole fraction POPE in
target vesicles constant at 30% or held the POPC/POPE
molar ratio constant at 2:1 (Fig. S3).
According to previous reports (9) and assays we have
performed on X:31 virus, influenza virus contains choles-
terol/phospholipid in a ~1:1 ratio. Therefore, we manipu-
lated the viral cholesterol composition via extraction with
methyl-b-cyclodextrin (MbCD) rather than by supplemen-
tation. We verified the efficiency of extraction using aA
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(18) and found a dose-dependent drop in cholesterol, with
75% depletion for 10 mMMbCD and nearly 90% depletion
for 50 mM MbCD (Fig. 4). Normalized fusion rates are
plotted as a function of MbCD dose in Fig. 3, C and D. In
contrast to the monotonic effect of liposomal cholesterol,
cholesterol extraction from the viral envelope yielded a
biphasic response: fusion rates increased from 0 to 10 mM
MbCD and then slowed down at 50 mM MbCD. For
20 mol % cholesterol vesicles, the lipid-mixing fusion rate
increased from 0.02 s1 without MbCD to 0.027 s1 when
virus was treated with 10 and 20 mM MbCD. Further
extraction from the virion reduced the fusion rate to
0.017 s1 at 50 mM MbCD. Similar trends occurred at
10 and 40 mol % cholesterol in the target vesicles (Figs. 2
and 3) and for lipid mixing as well as contents mixing.
Importantly, the extent of both lipid and contents mixing
decreased steadily with progressive extraction of cholesterol
(Fig. S4). It is the kinetics of the fusion process, rather than
the efficiency, that showed a biphasic response.
Cyclodextrin can be used as a bidirectional cholesterol
carrier, so to test the reversibility of cholesterol removal
from influenza virions, we performed replenishment experi-
ments by adding cholesterol back using a cholesterol-
MbCD carrier complex as previously described (19). We
observed full reversibility of cholesterol extraction, assayed
via both cholesterol content and fusion efficiency, at MbCD
concentrations as high as 20 mM. At 50 mM MbCD,
cholesterol content and fusion efficiency were both
partially restored (Fig. 4), indicating a loss of some viable
virus. Hemagglutination titers performed on virus treated
with 0 mM and 50 mM MbCD yielded measurements of30 40 50
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FIGURE 3 Response of fusion kinetics to
altered cholesterol levels in influenza virions or
target vesicles. Normalized fusion rates are plotted
to visualize trends more clearly; these correspond
to the unnormalized rates plotted in Figure 2.
(A and B) Rates of lipid (A) and contents (B)
mixing are plotted as a function of mol % choles-
terol in target vesicles. (C and D) Rates of lipid
(C) and contents (D) mixing are plotted as a func-
tion of the cholesterol/viral protein ratio after
cyclodextrin treatment. Significance was assessed
via the Kolmogorov-Smirnov test with a Bon-
ferroni multiple-hypothesis correction; ** denotes
a significant change from both the baseline and
the prior condition, p < 0.02. Error bars are plotted
as interquartile ranges. Trend lines are placed as
visual guides.
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FIGURE 4 Cholesterol depletion from and replenishment of influenza
virions. (A) Relative cholesterol depletion from X:31 influenza virions as
a function of MbCD treatment. Error bars are plotted as the SD over four
independent measurements per condition. Initial cholesterol levels were
measured at 0.155 0.0043 and 0.225 0.0153 ng cholesterol per micro-
gram of viral protein for batches A and B, respectively. (B) Results of
cholesterol replenishment experiments after extraction with 0, 20, or
50 mM MbCD. (C) Results of lipid-mixing efficiency experiments on
cholesterol-extracted and replenished virus. Extraction with 20 mM
MbCD is fully reversible, whereas extraction with 50 mM MbCD is
partially reversible. Values and error bars represent the mean and SD
calculated from four to six independent experiments per condition in
panel B and seven to 11 independent experiments per condition in panel C.
1386 Domanska et al.1:2560 for each sample in two independent experiments,
indicating that hemagglutination activity was intact to
within the 2-fold sensitivity of the assay (see Supporting
Material). Finally, methyl-b-cyclodextrin primarily extracts
sterols from lipid membranes, but related cyclodextrins can
bind other lipid components (20). We performed assays of
phosphate content on the cyclodextrin after extraction. At
10 and 20 mM MbCD, the phosphate content was at the
limit of detection, but at 50 mM MbCD, we cannot exclude
the possibility that some phospholipid was extracted fromBiophysical Journal 105(6) 1383–1387the viral membrane. It is therefore possible that the slowing
of fusion at 50 mM MbCD treatment may be due to a com-
bination of cholesterol extraction and other, minor changes
to membrane composition.
The curvature effects of cholesterol are especially impor-
tant for fusion because membrane fusion is believed to
proceed via highly curved intermediates (21). Low levels
of cholesterol impair influenza membrane fusion, as demon-
strated by prior work on influenza virus or hemagglutinin-
transfected cells (18,22). Similar effects have been seen in
model membranes (23). The theoretical explanation for
this is that cholesterol has a negative spontaneous curvature
(11) and reduces the energy of highly curved fusion inter-
mediates (24). Cholesterol can also be enriched in highly
curved regions of model membranes (10). In our experi-
ments, increasing the mole fraction of cholesterol in target
liposomes increased the viral fusion rates, which agrees
with hypothesis that cholesterol stabilizes the negative
curvature of high-energy fusion intermediates.
Cholesterol also controls the spatial localization of viral
fusion proteins, providing yet another mechanism to modu-
late fusion behavior. Influenza hemagglutinin localizes into
cholesterol-rich regions of cellular membranes (25), and this
localization is believed to be important for efficient fusion
(26). Cholesterol content can affect the patterning and
dynamics of viral envelopes, particularly because it alters
temperature-sensitive lipid-phase behavior (27). Because
multiple hemagglutinin trimers are believed to be necessary
for efficient fusion (28), changes to hemagglutinin spatial
patterning may alter the viral fusion kinetics. In this study,
cholesterol depletion from the viral envelope produced a
complex effect: moderate depletion increased the rate of
fusion and severe depletion slowed it significantly. This
biphasic behavior may reflect the different physical roles
of cholesterol in the viral membrane. Extraction may alter
hemagglutinin lateral distribution, mobility, lipid-phase
behavior, and the free energies of fusion intermediates.
Recent NMR spectroscopic studies on influenza virus
showed the coexistence of ordered and disordered lipid
domains, with a gel phase triggered by cholesterol depletion
(27). Such phase changes would also alter hemagglutinin
mobility.CONCLUSIONS
Our results suggest that sterol-dependent changes to the
viral envelope are multifunctional. This complexity itself
is not a surprise, but it is striking that the multiple mecha-
nistic roles of cholesterol can be seen in multiphasic fusion
kinetics. Consistent with prior observations, we observed
that both viral and target membrane cholesterol act to pro-
mote fusion efficiency, and depletion of either one reduces
efficiency. The complex effects of cholesterol are apparent
only in measurements of fusion kinetics. These effects can
be deconvolved by further experiments to probe the spatial
Cholesterol Effects on Influenza Fusion 1387organization and mobility of hemagglutinin in cholesterol-
depleted virus. Functional assays on live virus, as presented
here, are necessary to link these physical changes to viral
entry kinetics.SUPPORTING MATERIAL
Supportingmaterial, four figures, references (29,30), and one table are avail-
able at http://www.biophysj.org/biophysj/supplemental/S0006-3495(13)
00880-1.
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